Deal Watch, Amgen: ‘We’ve got a number of pretty interesting prospects’
Last fall, the Financial Times managed to get heads to turn when it quoted sources saying that Amgen was looking for an acquisition worth …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
